AFP and hepatocellular carcinoma: Thus, AFP combination of ALT, AST, and NLR was superior to any single indicator or any combinations of each biomarkers, except in the CHB patients without cirrhosis group, and displayed a good diagnostic performance for detecting HBV‐HCC among almost all subgroups.